The QualityStocks Daily Friday, November 16th, 2018

Today's Top 3 StockMarketWatch

QualityStocks (USEL) +612.12%

StocksToBuyNow (HOILF) +330.71%

MarketBeat (CLY:CA) +100.00%

The QualityStocks Daily Stock List

Freedom Leaf, Inc. (FRLF)

InvestorsHub, CFN Media Group, SmallCapVoice, MicroSmallCap, Promotion Stock Secrets, Daily Marijuana Observer, OTC Markets, Stockhouse, Penny Stock Tweets, and Stocks To Buy Now reported on Freedom Leaf, Inc. (FRLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a group of global, vertically integrated hemp businesses and cannabis media companies. It is a foremost go-to resource in the cannabis, medical marijuana, and industrial hemp industry. Freedom Leaf is building a varied portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry. Leafceuticals, Inc. is a wholly-owned division of Freedom Leaf. Freedom Leaf is headquartered in Las Vegas, Nevada and the Company lists on the OTCQB.

Freedom Leaf targets acquisitions of high growth and niche companies. Its strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development. Freedom Leaf does not handle, grow, sell, or disperse marijuana.

Freedom Leaf has its This is the Spanish Speaking community's foremost cannabis website. In addition, Freedom Leaf has its This is the largest Medical Cannabis information website in Spanish.

The Company’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-developing and changing cannabis, medical marijuana, and industrial hemp industry.

Hempology® is the Company’s exclusively branded product line. Hempology® is now vertically integrated from seed to consumer, processing CBD and a whole spectrum of whole-hemp extracts for the entourage-effect. Moreover, Freedom Leaf has its hemp-based rolling paper company, Plants to Paper.

Freedom Leaf has acquired 100 percent of Green Market Europe S.L. (GME). GME is a Spanish producer of hemp products. Freedom Leaf has also acquired the Irie CBD Product Line. This includes virtually all assets, trademarks, formulating equipment, formulas and products. Irie is a California-based CBD, "Cannabidiol", product line. Furthermore, Freedom Leaf announced this past August that it consummated a 100 percent acquisition of Tierra Science Global, LLC. Tierra specializes in health supplements supporting peak bio-energy levels in humans.

This week, Freedom Leaf announced that it entered into a Letter of Intent (LOI) to acquire Hemp2o, a brand of hemp-infused beverages co-founded by San Francisco cannabis entrepreneur and rapper Gilbert Milam Jr., better known by his stage name Berner. Hemp2o’s beverages are presently sold by national retailers. This transaction involves a combination of cash and Freedom Leaf stock and is expected to close in December.

Cliff Perry, Freedom Leaf Chief Executive Officer, stated, "We are excited to welcome Hemp2o into the Freedom Leaf family, and look forward to expanding our national footprint based on their success of established authorized accounts in some of the largest retailers in the U.S. We believe that our consolidated sales teams and expanded product selection will increase revenue through both of our respective channels."

Freedom Leaf, Inc. (FRLF), closed Friday's trading session at $0.33, up 5.57%, on 699,976 volume with 151 trades. The average volume for the last 3 months is 2,167,432 and the stock's 52-week low/high is $0.038/$0.795.


Innovative Food Holdings, Inc. (IVFH)

MissionIR, Equity Clock, StockInvest, Simply Wall St, Tip Ranks, Stockopedia, YCharts, The Bowser Report, Penny Stock Tweets, Investors Hangout, Dividend Investor, Plunkett Research, Marketbeat, Stock Guru, FeedBlitz, Capital Cube, and Wallet Investor reported previously on Innovative Food Holdings, Inc. (IVFH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Innovative Food Holdings, Inc. is an industry leading specialty food platform. The Company, via its subsidiaries, is a top nationwide provider of direct from source specialty foods, healthcare foods, gluten free foods, and artisanal foods, to the professional foodservice market. Perishable product is delivered direct to the Company’s kitchen the next day through overnight delivery. Non-perishable product is delivered direct to customers. OTCQB-listed, Innovative Food Holdings is based in Bonita Springs, Florida.

For Chefs (Chef Direct), the Company’s vertically-integrated platform enables it to source 7,000-plus specialty foods globally and deliver within 24-72 hours. Innovative Food Holdings’ subsidiaries include Artisan Specialty Foods and Innovative Gourmet. Artisan Specialty Foods is a nationwide specialty food distributer, re-packer, and importer. Artisan serves hundreds of customers in the Chicago area. Artisan also serves as a nationwide fulfillment center for other Innovative Food Holdings subsidiaries operating in the foodservice and direct-to-consumer markets.

Innovative Food Holdings supplies chefs with unique, organic, sustainable, and artisanal products sourced from all areas around the world. The Company markets its products directly to the consumer, by way of its website at

Innovative Food Holdings announced this past January that its subsidiary, Innovative Gourmet, acquired substantially all the assets of one of North America’s leading online gourmet food and gift retailers. The business will operate under igourmet’s valued and trusted trade name. igourmet offers a wide array of high quality gourmet and specialty food products by way of, and through a complete line of omnichannel partners. Additionally, igourmet offers a broad variety of specialty food products to restaurants, specialty retailers and other business establishments through its specialty foodservice division.

This week, Innovative Food Holdings reported financial results for Q3 ended September 30, 2018. Q3 2018 Revenues were $12,054,490 versus Revenues of $10,495,637 for Q3 2017. The 15 percent increase in Q3 2018 Revenues was mainly driven by growth from the Company's subsidiary, Innovative Gourmet.

Q3 2018 Net Income was $148,701, or $0.004 per diluted share, versus $1,532,892 or $0.05 per diluted share for Q3 2017. Cash EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) was $495,216 versus Cash EBITDA of $1,673,044 for Q3 2017. The Innovative Gourmet business is a highly seasonal business. Greater than 40 percent of the Company’s Revenues are normally recorded in Q4.

Innovative Food Holdings, Inc. (IVFH), closed Friday's trading session at $0.49, down 9.26%, on 319,474 volume with 52 trades. The average volume for the last 3 months is 57,981 and the stock's 52-week low/high is $0.443/$1.38.


Regulus Therapeutics, Inc. (RGLS)

Zacks, Stock Twits, Stock News Gazette, Investor Network, Simply Wall St, YCharts, InvestorsHub, 4-Traders, MarketWatch, Stockhouse, Nasdaq, and The Street reported on Regulus Therapeutics, Inc. (RGLS), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Regulus Therapeutics, Inc. is leading the discovery and development of unique medicines targeting microRNAs. It is advancing a number of programs in renal, hepatic and central nervous systems diseases. A clinical stage biopharmaceutical company, Regulus Therapeutics was formed in September of 2007 by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, now Ionis Pharmaceuticals (IONS). Regulus Therapeutics is based in La Jolla, California.

The Company has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline. This pipeline is complemented by a rich intellectual property (IP) estate. Together, this enables Regulus to retain its leadership in the microRNA field.

Regulus Therapeutics has its RG-012 for Alport syndrome and RGLS4326 for autosomal dominant polycystic kidney disease (ADPKD). Alport syndrome is an inherited form of kidney disease. It is caused by mutations in the type IV collagen genes (Col4A3, Col4A4 and Col4A5). RG-012 is undergoing development by Regulus in a strategic alliance with Genzyme, a Sanofi company, for the treatment of Alport syndrome.

RG-012 is a single stranded, chemically modified oligonucleotide. It binds to and inhibits the function of miR-21 for the treatment of Alport syndrome. ADPKD is caused by the mutations in the PKD1 or PKD2 genes. ADPKD is among the most common human monogenetic disorders. Furthermore, it is a leading genetic cause of end-stage renal disease. RGLS4326 is a novel oligonucleotide. The design of it is to inhibit miR-17 utilizing an innovative chemistry design to preferentially target the kidney.

Regulus Therapeutics and STA Pharmaceutical Co., Ltd. (STA) entered into an oligonucleotide synthesis collaboration agreement this year for research and mid-scale non-GMP/cGMP manufacturing. STA is a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing.

Regarding RG-012 for Alport syndrome, patient recruitment activities for the Phase II HERA and the renal biopsy studies are continuing.  Based on revised enrollment assumptions, Regulus Therapeutics believes that both studies will be fully enrolled in the second half of 2018.

Pertaining to RGLS4326 for autosomal dominant polycystic kidney disease (ADPKD), a Phase I SAD study was started in December of 2017.  Data from the study in healthy volunteers will provide pharmacokinetics and safety data.

Last week, Regulus Therapeutics announced that it amended and restructured its Collaboration and License Agreement with Sanofi.  Under the terms of this Amendment, Regulus granted Sanofi a global exclusive license to develop and commercialize its investigational drug, targeting miR-21 for all indications, including Alport syndrome. Under the Amendment, Sanofi will assume all future costs and development activities associated with the advancement of RG-012, now in Phase 2 for Alport syndrome.

This past September, and in consultation with the Food and Drug Administration (FDA), Regulus Therapeutics initiated a new 27-week chronic mouse toxicity study for RGLS4326 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), incorporating a number of changes believed to address the unexpected findings in the earlier terminated chronic mouse toxicity study. The study is ongoing, and data are expected in Q1 2019.

Last month, Regulus Therapeutics presented three posters during the American Society of Nephrology's Kidney Week describing the discovery and preclinical evaluation of RGLS4326, a novel single-stranded, chemically-modified oligonucleotide designed to preferentially target the kidney and inhibit miR-17 functions to treat ADPKD. In preclinical studies, RGLS4326 inhibited miR-17 activity and lessened cyst formation and proliferation of primary cyst cultures derived from human donors with ADPKD.

Regulus Therapeutics, Inc. (RGLS), closed Friday's trading session at $1.44, up 9.09%, on 446,855 volume with 708 trades. The average volume for the last 3 months is 470,621 and the stock's 52-week low/high is $1.04/$17.28.


Research Solutions, Inc. (RSSS) and Wall Street Resources reported earlier on Research Solutions, Inc. (RSSS), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Research Solutions, Inc. is an innovator in providing cloud-based solutions for scientific research. The Company is a pioneer in cloud-based SaaS (Software-as-a-Service) research intelligence products and services for research-intensive organizations. Research Solutions has its wholly-owned subsidiary Reprints Desk, Inc. The Company’s cloud-based SaaS platform provides customers with on demand access to, and augmented data from, tens of millions of scientific, medical, and technical (STM) documents. This is in addition to tens of millions of articles beforehand published.  Research Solutions has its corporate headquarters in Encino, California.

Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Reprints Desk and Altmetric LLP previously agreed to integrate Altmetric badges to scholarly content obtained via Reprints Desk's award-winning research retrieval platform Article Galaxy. Altmetric is a top research metrics provider.

The Altmetric badges provide an at-a-glance visualization of the attention a particular journal article has received online from mainstream and social media, public policy documents, blogs, Wikipedia, and scholarly forums. These help scientists in assessing the reach and influence of research.

Research Solutions and its wholly-owned subsidiary Reprints Desk have launched a new version of the Company's award-winning Article Galaxy research platform. New features include full mobile responsiveness, design enhancements, an improved order history page, and the introduction of an ecosystem of gadgets - robust applications that allow for sophisticated data augmentation of content.

Reprints Desk has signed separate reseller agreements with Ritme and Alfasoft to deliver new tools and services that address the complete range of knowledge acquisition and information management requirements of researchers in scientific, technical, and also medical (STM) fields.

In May, Research Solutions reported financial results for its fiscal Q3 ended March 31, 2017. Total revenue was $8.6 million versus $8.7 million in the year-ago quarter. Platform revenue was up 124 percent to $270,920, with a 152 percent increase in total Platform deployments to 116. Annual recurring revenue was up 127 percent to $1.1 million.

Customer count was up 9 percent to 985. Transaction count was up 7 percent to 212,827. Transaction revenue was basically unchanged at $6.4 million.  Net loss was $(0.6) million, or $(0.03) per share, versus net income of $32,000 or $0.00 per share. This loss was because of Research Solutions’ continued investment in its rapidly growing, recurring revenue Platform business.

Recently, Outsell, Inc. gave Research Solutions and Reprints Desk top ratings for its recently released version of the Article Galaxy SaaS research platform. Outsell is the globe’s only research and advisory firm centered on media, information, and technology. The Outsell Insights published on April 21, 2017 concludes that Reprints Desk is delivering a considerably improved service to researchers, which provides an enhanced user experience and creates efficiencies within end-user workflows focused around app-like gadgets.

Research Solutions, Inc. (RSSS), closed Friday's trading session at $2.45, up 8.89%, on 7,150 volume with 20 trades. The average volume for the last 3 months is 8,930 and the stock's 52-week low/high is $1.03/$2.59.


Lexington Biosciences, Inc. (LXGTF)

Awesome Penny Stocks, Penny Stock Hub, MarketWatch, Morningstar, Interactive Brokers, TradingView, Dividend Investor, Tech Stock Insider, InvestorsHub, Wallet Investor, 4-Traders, and Market News Updates reported earlier on Lexington Biosciences, Inc. (LXGTF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

A medical device company, Lexington Biosciences, Inc. is developing the HeartSentry. This is a new non-invasive diagnostic device to measure and monitor cardiovascular health through assessing the function of a person's vascular endothelium. This is the vital innermost lining of a person's cardiovascular system. The Company’s aim is to become a leader in the development of clinical grade cardiovascular self-measurement solutions for home and clinical use. Lexington Biosciences has offices in Vancouver, British Columbia; and Reno, Nevada.

Lexington is engaged with the US FDA (Food and Drug Administration) and other regulatory agencies on the required product approvals for the HeartSentry.  HeartSentry targets the fast-growing self-measurement medical device sector. The design of the HeartSentry unit is to use Bluetooth and Cloud technology to provide up-to-date and accurate readings of an individual’s total cardiovascular health via electronic monitoring for risk-assessment and treatment effectiveness targeting the prevention of heart attack and stroke.

HeartSentry is its flagship, and first device currently advancing to commercial deployment. The HeartSentry core technology underwent development at the University of California Berkeley over a fifteen-year research and development (R&D) period involving many research studies and product iterations resulting in a portfolio of numerous pending and issued patents licensed to Lexington Biosciences.

Lexington Biosciences announced earlier this year the completion of the initial HeartSentry study conducted at San Francisco Bay-area Diablo Clinical Research. Lexington Biosciences’ goal is to make HeartSentry accurate, fast, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person's cardiovascular health.

Over this past summer, Lexington Biosciences completed its first phase of clinical testing at Diablo Clinical Research. The results of the study validated safety protocols, provided Lexington with critical information for product iteration, algorithm development, and clinical testing protocol refinement in preparation for the forthcoming multi-center clinical study series.

Lexington Biosciences, Inc. (LXGTF), closed Friday's trading session at $0.0927, up 2.64%, on 42,620 volume with 10 trades. The average volume for the last 3 months is 107,933 and the stock's 52-week low/high is $0.0482/$0.4844.


NeuroOne Medical Technologies Corporation (NMTC)

Penny Stock Hub, Wallmine, Marketbeat, Business Insider, InvestorsHub, The Stock Market Watch, YCharts, OTC Markets, Street Insider, Trading View, 4-Traders and Stockopedia reported earlier on NeuroOne Medical Technologies Corporation (NMTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NeuroOne Medical Technologies Corporation focuses on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is changing the landscape of surgical care for neurological disorders through the development of high-definition, minimally invasive diagnostics and treatments. OTCQB-listed, NeuroOne Medical Technologies has its corporate office in Eden Prairie, Minnesota.

The Company concentrates on the development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson’s Disease, Dystonia, Essential Tremors and other related brain related disorders. NeuroOne Medical believes that technology in its pipeline can improve outcomes through reducing the risk of infection; lessening inflammation of the brain during recording; and increasing accuracy and specificity of recorded brain activity.

It also believes that technology in its pipeline can improve outcomes through minimizing invasiveness of the procedure; and reducing time-consuming, cumbersome, and expensive technical use and management within facilities. NeuroOne Medical’s emphasis is on the development and commercialization of Diagnostic Recording and Therapeutic Modalities.

In 2017, NeuroOne Medical Technologies completed early feasibility testing for depth electrode and combination diagnostic/ablation depth electrode. Furthermore, the Company established its Physician Advisory Board and raised more than $1.8 million in private transactions. The Company also completed a reverse merger and up-listed to the OTCQB.

The primary current goals for NeuroOne Medical Technologies are to file patent application(s) based on the submitted 2017 provisional patents, and complete pre-clinical study for its diagnostic and diagnostic/ablation combination depth electrode. Primary goals also include submitting a 510(k) application for cortical electrode in 2018, ramping up production and hiring initial sales force representatives for cortical electrode. In addition, primary goals include continuing to strengthen its Physician Advisory Board where appropriate.

This week, NeuroOne Medical Technologies introduced five members, which have been appointed to its new Artificial Intelligence Advisory Board. In Q3 2018, it announced the creation of a seven member advisory board to be chaired by Dr. Kip Ludwig of the Bioelectronic Medicines Laboratory at the University of Wisconsin. The advisory board will provide guidance to NeuroOne Medical on the potential use of the Company’s electrode technology in bioelectronics, neuromodulation and artificial intelligence applications. Additionally, they will assist NeuroOne with evaluating additional translational science applications for the Company’s electrode technology beyond the initial diagnostic and therapeutic indications.

NeuroOne Medical Technologies Corporation (NMTC), closed Friday's trading session at $5.09, down 2.86%, on 290 volume with 3 trades. The average volume for the last 3 months is 6,370 and the stock's 52-week low/high is $2.50/$10.00.


Grizzly Discoveries, Inc. (GZDIF)

MissionIR, Stockhouse, MarketWatch, 4-Traders, Investing News, Morningstar, Investor Ideas, Junior Mining Network, MineSnooper, Mining, Marketwired, YCharts, TradingView, InvestorsHub, Stockstream, and The Prospector News reported earlier on Grizzly Discoveries, Inc. (GZDIF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Grizzly Discoveries, Inc. centers on developing its precious metals properties in southeastern British Columbia, and significant Potash and Diamond assets in Alberta. The Company chiefly explores for gold, silver, copper, lead, zinc, potash, and diamond deposits. Incorporated in 2002, the Company has its corporate office in Edmonton, Alberta. A diversified mineral exploration enterprise, Grizzly Discoveries lists on the OTCQB.

The Company holds or has an interest in greater than 180,000 acres of precious-base metal and cobalt properties in British Columbia; and metallic and industrial mineral permits for potash totaling more than 60,000 acres along the Alberta-Saskatchewan border. Additionally, it has an interest in over 161,000 acres of properties that host diamondiferous kimberlites in the Buffalo Head Hills region of Alberta.

Grizzly Discoveries has entered into a Letter of Intent (LOI) with a private group to purchase the Cobalt-Copper-Silver "Robocop Property", situated within the Fort Steele Mining District in southeastern British Columbia. The Robocop Property is about 45 kilometers (km) south of Fernie and 70 km southeast of Cranbrook. The Property is immediately north of the Canada-U.S. border. The Property consists of 5 mineral claims totalling 9,891 acres. The Robocop Property is east of Grizzly Discoveries’ Greenwood Property in southeastern British Columbia.

This past September, Grizzly Discoveries announced that Kinross Gold Corporation's wholly-owned subsidiary, KG Exploration (Canada), Inc. informed Grizzly that they completed the drill program within the Greenwood Project, positioned near Greenwood in southern British Columbia, as announced on July 26, 2018. Furthermore, Grizzly has started exploration activities at its recently acquired Robocop property by mobilization of a field crew in advance of an airborne geological survey.

Regarding Greenwood, Kinross undertook a planned 1,200 m drill program at the Midway area during July and August 2018, to continue the proof of concept drilling at the Midway Epithermal Target intersected in 2017. Proof-of-concept drilling in 2017 intersected silicification, alteration, anomalous geochemistry, and also minor quartz veining in 2 out of 3 holes along strike, warranting more follow-up exploration. Further details of the results will be provided from Kinross upon the completion of logging, sampling and assaying.

Grizzly Discoveries, Inc. (GZDIF), closed Friday's trading session at $0.075, down 3.85%, on 62,100 volume with 3 trades. The average volume for the last 3 months is 12,680 and the stock's 52-week low/high is $0.0261/$0.114.


Wizard World, Inc. (WIZD)

Wall Street Resources and TopPennyStockMovers reported earlier on Wizard World, Inc. (WIZD), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Wizard World, Inc. is the foremost provider of multiple Comic Cons and pop culture conventions around the world. The Company produces Comic Cons (live multimedia conventions) and pop culture conventions. These celebrate pop-fi, pop culture, movies, television, cosplay, comics, graphic novels, toys, video gaming, sci-fi, gaming, original art, collectibles, contests and more. Wizard World has its headquarters in El Segundo, California. The Company’s shares trade on the OTC Bulletin Board (OTC BB).

Wizard World’s events frequently feature celebrities from movies and TV, artists and writers, and events such as premieres, gaming tournaments, panels, as well as costume contests. The Company has its ComicConBox™. This is a subscription-based premium monthly box service. It provides fans the opportunity to receive exclusive collectibles, toys, technology, games, licensed artwork, comics, apparel, Wizard World Comic Con tickets, VIP discounts and more, delivered to their doors.

The Company’s Comic Cons provide sales, marketing, promotions, public relations, advertising, and sponsorship opportunities for entertainment companies, toy companies, gaming companies, publishing companies, marketers, corporate sponsors, and retailers.

Wizard World Digital is the Company’s online publication. It covers new and upcoming products and talents in the pop culture world. Also, Wizard World has established a new SocialCon™ Operating Unit within Wizard World. SocialCon™ will produce a series of conventions. These will feature meet-and-greets, live performances, Q&A panels, autographs, photo opportunities and more with many of today’s most-followed social media influencers.

In addition, Wizard World has its CONtv. This is a subscription-based digital service. It brings fans their favorite films, TV series, comics, behind the scenes access to Wizard World Comic Cons, and more.

CONtv provides consumers access to thousands of hours of exclusive content highlighting an original slate of programming and a comprehensive digital catalog of over 1,200 titles. Furthermore, Wizard World has launched the new music concert series, and the Wizard World Store.

In September 2017, Wizard World announced its partnership with CNLive to distribute streamed content in the People's Republic of China (PRC). This partnership with CNLive, one of only seven entities licensed to distribute content over the internet in the PRC, provides Wizard World China, a wholly-owned subsidiary of Wizard World, a multi-year right and license to program a 24/7, advertising supported channel throughout all of mainland China. This includes Macao and Hong Kong.

Wizard World, Inc. (WIZD), closed Friday's trading session at $0.13, up 8.33%, on 3,500 volume with 1 trade. The average volume for the last 3 months is 10,163 and the stock's 52-week low/high is $0.11/$0.33.


LiCo Energy Metals, Inc. (WCTXF)

Penny Stock Hub, Dividend Investor, Emerging Growth, Stockhouse, InvestorsHub, Barchart, SmallCapVoice, Metals News, Market Screener, Streetwise Reports, OTC Markets, MarketWatch, and Stock of the Week reported on LiCo Energy Metals, Inc. (WCTXF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LiCo Energy Metals, Inc. conducts exploration for metals used in the production of lithium-ion batteries. The Company has four ongoing projects in mining-friendly jurisdictions within the U.S., Canada, and Chile. It has a growing portfolio of promising projects, all with objectives of developing battery-grade lithium or cobalt. OTCQB-listed, LiCo Energy Metals is headquartered in Vancouver, British Columbia.

The Company’s projects include the Glencore Bucke Property, the Teledyne Cobalt Project, the Purickuta Exploitation Project, the Dixie Valley Lithium Project, and the Black Rock Desert Lithium Project. The Glencore property comprises 16.2 hectares. It sits along the west boundary of LiCo’s Teledyne Cobalt Project.

The Teledyne Cobalt Project consists of 5 mining claims and 6 staked crown claims in the Buck and Lorrain Townships, in the district of Temiskaming, Ontario. This project encompasses 115.5 hectares of mining and surface rights, with an additional 439.1 hectares of staked crown claims.

The Purickuta Project comprises 160 hectares. It is one of a few "exploitation concessions" granted within the Salar de Atacama, home to approximately 37 percent of the world’s Lithium production.

LiCo Energy Metals announced in April 2018 its proposed Exploration Programs for its Teledyne & Glencore Bucke Cobalt Properties in Ontario. Concerning the Glencore Bucke Cobalt Property, a surface exploration work program including geological mapping and prospecting is recommended to further evaluate the geological potential of the Property.

For the Teledyne Cobalt Property, a surface exploration work program including geological mapping, prospecting, and mechanized stripping is recommended for the Property. LiCo's previously completed diamond drilling program (September to December 2017) consisted of twinning and infill drilling of the historical drill holes situated on the Teledyne Cobalt and Glencore Bucke Properties.

Moreover, LiCo Energy Metals earlier entered into an option to acquire 100 percent, Net 3 Percent Smelter royalty to acquire 348 claims in the Dixie Valley Exploration Project in Churchill County, Nevada. In addition, the Company entered into an option agreement where it may earn an undivided 70 percent interest subject to a 3 percent Net Smelter Return Royalty in the existing Black Rock Desert Lithium Project. This Project comprises 199 placer claims (3,980 acres/1,610 hectares) in southwest Black Rock Desert, Washoe County, Nevada.

LiCo Energy Metals, Inc. (WCTXF), closed Friday's trading session at $0.07949, down 3.06%, on 23,904 volume with 7 trades. The average volume for the last 3 months is 118,226 and the stock's 52-week low/high is $0.0141/$0.8949.


Vegalab, Inc. (VEGL)

OTC Markets, Simply Wall St, YCharts, Investors Hangout, Stockwatch, Capital Cube, Barchart, MarketWatch, InvestorsHub, TradingView,, PennyStockHub, and reported on Vegalab, Inc. (VEGL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Vegalab, Inc. is the exclusive distributor in North and South America of a line of all-natural, biologically derived pesticides, fertilizers, and specialty agricultural products. The Company’s products support a healthy soil biome. Additionally, they are cost competitive with synthetic chemicals that do just the opposite. The Company formerly went by the name HPC Acquisitions, Inc. It changed its corporate name to Vegalab, Inc. in November 2017. OTCQB-listed, Vegalab is based in North Palm Beach, Florida.

The Company’s products include Biocontrol Agents, Insecticides, Fungicides, Soil Inoculants, and Fertilizers. All of its oil-based products go through a process of micronization. This gives these oils the ability to cover a larger surface area and enabling deeper penetration into the crevices of plants, insects, and pathogens. The minute pores and filaments in the plant absorb Vegalab’s products faster in comparison to conventional oils.

Vegalab’s pesticides are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. Every Vegalab product strives to enhance productivity and decrease waste. The Company’s formulas and processes are the result of years of biological research and development (R&D), producing eco-safe, all-natural products.

Vegalab US purchased substantially all of the assets related to a produce packaging business in Tulare County, California. The acquisition closed on October 18, 2017.

The acquisition consisted of the purchase of approximately 11 acres of real property and 30,000 sq. ft. of buildings from M & G Farms, Inc. (a California corporation) and all of the equipment, inventory, customers, suppliers, contract rights, and intangible property from M&G Packing, Inc., the California Corporation that operated the Business.

Earlier in 2018, Vegalab announced the successful trials of its Pollen Boost product and initial first orders of Pollen Boost, which were for delivery in early February from Stanislaus Farm Supply, Buttonwillow Warehouse Company, and Mid Valley Agricultural Services, Inc.  The successful trials and first orders for Pollen Boost are a culmination of Vegalab’s focus on market leading, Earth friendly products that give farmers a substantial Return on Investment (ROI).

This past February, Vegalab provided a business update on M&G Packing that was purchased on October 18, 2017. The facility comprises roughly 11 acres of real property and 30,000 sq. ft. of buildings.

M&G Packing had about $8.6 million in fruit sales during the fiscal year (FY) ended September 30, 2017. Net income from operations for the period was $83,128. After the acquisition of M&G, the Company has received orders and shipped product at a level it believes to be consistent with M&G operations in its FY 2017.

In March, Vegalab announced that it completed its acquisition of The Agronomy Group, LLC effective as of February 1, 2018. The Agronomy Group (TAG) is located in Tulare County, California. It is a producer and distributor of environmentally friendly agrochemicals and also distributes other products. TAG had been Vegalab’s leading U.S. sales organization. Consequently, this acquisition significantly expands Vegalab’s internal marketing capability.

Vegalab, Inc. (VEGL), closed Friday's trading session at $1.75, up 0.57%, on 500 volume with 4 trades. The average volume for the last 3 months is 684 and the stock's 52-week low/high is $0.509/$5.24.


SCI Engineered Materials, Inc. (SCIA)

InvestorsHub and OTC Markets reported on SCI Engineered Materials, Inc. (SCIA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

SCI Engineered Materials, Inc. is a global supplier and manufacturer of advanced materials for physical vapor deposition (PVD) thin film applications. This includes thin film solar products. The Company works closely with end users and original equipment manufacturers (OEMs) to develop unique, customized solutions. It provides targeted solutions for thin film applications. OTCQB-listed, SCI Engineered Materials is based in Columbus, Ohio.

The Company is an ISO 9001-2015 Registered Provider of PVD Materials. It is a “Full Service Materials Provider” for PVD applications. SCI is a recognized leader in the development of “Transparent Conductive Oxide (TCO)” materials for varied industries. SCI continues development with Universities and Research Institutes internationally.

SCI provides ceramic and metal targets for use in sputtering and laser ablation systems. Furthermore, the Company manufactures high performance metal, ceramic, and alloy bulk-form evaporation sources in almost any customer defined configuration.

In addition, SCI processes a wide assortment of custom ceramic powders in house. It offers a broad variety of single crystal substrates for making first-class thin films. Services that SCI provides include advanced ceramic powers, vacuum hot pressing, machining, bonding, and quality assurance.

The major markets that SCI Engineered Materials serves include architectural glass, optic & photonic, solar photovoltaic, transparent electronics, and solid state lithium thin film battery. The Company provides precision machining of backing plates & tubes to customer or OEM specifications.

SCI Engineered Materials announced in June of last year that it entered into a joint project with Case Western Reserve in their Summer Undergraduate Research in Energy and Sustainability program. The objective of the project is to measure the band gaps and work function of several materials now undergoing development by SCI through in-house research and development (R&D) activities.

Case Western Reserve was to evaluate test films to determine if SCI's materials have superior properties to replace Cadmium Sulfide and/or intrinsic Zinc Oxide in Copper Indium Gallium Selenide (CIGS) thin film solar products.

Subsequent, SCI Engineered Materials announced Case Western Reserve University’s (CWRU) successful evaluation of test films utilizing SCI’s Zinc Magnesium Oxide (MZO) material. The results support use of SCI’s innovative material in thin film solar applications that could lead to higher efficiencies. Yesterday, SCI Engineered Materials reported its financial results for the twelve months and three months ended December 31, 2017.

Mr. Dan Rooney, the Company’s President & Chief Executive Officer, said, “The positive 2017 results can be attributed to changes in the strategy we implemented during in the second half of 2016. These achievements included a 24 percent increase in revenue, a 45 percent increase in gross profit and a 12 percent decrease in operating expenses compared to 2016; resulting in net income of $6,091 compared to a net loss of $(706,054) in 2016. EBITDA for the year 2017 was more than $519,000, the highest annual amount since 2010.”

SCI Engineered Materials, Inc. (SCIA), closed Friday's trading session at $3.00, even for the day, on 2,001 volume with 14 trades. The average volume for the last 3 months is 5,523 and the stock's 52-week low/high is $0.62/$3.39.


TSS, Inc. (TSSI), RedChip, and Wall Street Resources reported earlier on TSS, Inc. (TSSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

TSS, Inc. is a systems integration and mission critical data center technology services company. TSS is a single source provider of mission-critical planning, design, system integration, deployment, maintenance, and development of data centers facilities and information infrastructure. The Company is an innovator in the hyper-dynamic mission-critical facilities industry. TSS provides a single-source solution for mission-critical facilities. Its expertise is in information Technology (IT) and integrated facilities services. Listed on the OTC Markets’ OTCQB, TSS has its headquarters in Round Rock, Texas.

The Company has worked across many industries. It has planned, designed, built, and also maintained specialized facilities. These include data centers, communications rooms, SCIFs, call centers, laboratories, trading floors, network operations centers, and medical facilities.

TSS is an innovator and leader in mission-critical infrastructure design and support services. These include Modular Data Centers, Assessments & Audits, Design & Budgeting, Project & Construction Services, Operations & Maintenance, and Planning & Analysis or Transformation Services.

The Company’s Data Center Services include Modular Data Centers; Data Center Health Check; Facility Assessment; Owners Representation; and Strategic Options Analysis. Its Services also include CFD Assessment; Data Center Transition Planning; Information Technology (IT) Equipment Relocation Services; as well as Arc Flash-Hazard Analysis.

TSS specializes in customizable end-to-end solutions powered by industry experts and creative services. These include technology consulting, engineering, design, project management, operations, facilities management, technology system installation and integration, and maintenance for traditional and modular data centers.

The Company integrates a facility’s electrical, mechanical, security, and building envelope into a unified strategic asset. TSS’s objective is to provide its customers with the most advanced and reliable mission-enabling solutions. The Company provides end-to-end solutions for all aspect of a client’s critical facility projects.

TSS’s solutions include Modular Data Centers (MDCs). It provides MDC solutions that help customers’ to cost-effectively design and deploy a data center based on quality, scalability, maintainability, and portability. TSS can provide a customer with design, engineering, installation, and maintenance services to configure and support solutions unique to their needs.

Recently, TSS announced it was recognized by Dell EMC as the Best Partner in a Crisis for 2017. TSS was recognized for its unique and quick response architecting a remediation plan and mobilizing a substantial number of resources in record time to remedy a suspected quality issue within two data centers of one of the globe’ largest financial institutions, a new large acquisition account for Dell EMC in the first half of 2017.

This week, TSS reported results for its Q3 ended September 30, 2017. The Company had Q3 2017 Revenue of $4.9 million versus $5.4 million in Q3 of 2016 and $4.2 million in Q2 of 2017.

Its Gross Margin was 42 percent in Q3 of 2017 versus 27 percent in Q3 of 2016. Net Income was $298,000 or $0.02 per share in Q3 2017 versus Net Income of $165,000 or $0.01 per share in Q3 2016.

TSS, Inc. (TSSI), closed Friday's trading session at $0.90994, up 2.49%, on 14,050 volume with 17 trades. The average volume for the last 3 months is 19,256 and the stock's 52-week low/high is $0.3105/$0.91.

chart, Inc. (USEL)

TopPennyStockMovers, Wall Street Resources, RedChip, Ceocast News,, Wall Street Mover, InsiderPennyStocks, and The Research Report reported earlier on, Inc. (USEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter., Inc. is a re-Commerce marketplace. This marketplace helps individuals, carriers, and retailers turn used smartphones into cash.’s mission is to change the way people change up their technology. uSell makes it easy for people to sell their used gadgets via connecting them with numerous professional buyers, so they can get the best offers.

Fundamentally, uSell is a technology driven enterprise focused on extracting the maximum value from used mobile devices. uSell is headquartered in New York, New York. The Company lists on the OTCQB.

For sellers, the emphasis is on finding the best offers fast. A seller selects a buyer. They subsequently send in their gadget for free. They then get paid in cash, quickly. uSell helps sellers in that after a seller picks their device, uSell shows them the best offers from its network of buyers.

The seller can sell and ship for free. After they accept a cash offer, uSell sends them a pre-paid shipping kit and tracking is included. The seller gets paid quickly via PayPal or check. Their buyer will issue payment within five business days of receiving the seller’s device.

For its buyers, uSell provides a scalable technology, marketing, logistics, and analytics solution. This solution provides a high volume of inventory at a low acquisition cost. uSell brings the most reputable buyers onto one platform.

Buyers compete to purchase peoples’ gadgets. Furthermore, the offers uSell lists are the highest in the industry. The Company’s buyers are professional organizations with positive user reviews and first-rate customer service. previously acquired top tier smartphone wholesaler, We Sell Cellular LLC. We Sell Cellular has access to supply from trade in programs of major carriers and big box retailers. uSell acquires products from individual consumers, on its website,, and from major carriers, big box retailers, as well as manufacturers through its subsidiary, We Sell Cellular.

For the three-month period ended September 30, 2017, uSell launched a new platform to enable select buyers to buy directly through an online website. In addition, the Company continued to invest in warehouse operations to increase capacity, reduce processing lead-time, and provide device level traceability to suppliers.

Recently, announced the closing of a $3.94 million private placement. The common stock investment was done at a fixed price of $0.50 or above the public market price.

Nik Raman,’s Chief Executive Officer, said, "Our recent financing was strategically timed to enable us to take advantage of the upcoming iPhone X trade-in cycle. As demonstrated by our recently reported record quarterly revenue and gross merchandise volume, we have expanded relationships with both new and existing suppliers over the last year, and we believe that these relationships will continue to develop in 2018.", Inc. (USEL), closed Friday's trading session at $0.235, up 612.12%, on 2,498 volume with 3 trades. The average volume for the last 3 months is 913 and the stock's 52-week low/high is $0.021/$0.60.


American Power Group Corp. (APGI)

Stock News Now,, and SmallCapVoice reported on American Power Group Corp. (APGI), and we also report on the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. is a designer and producer of proven alternative fuel solutions. These are for stationary power generators, backup power systems, as well as commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, and off-road mobile diesel engines. American Power Group is based in Lynnfield, Massachusetts.

The Company (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs), which can sell as heating fluids, emulsifiers, or be further processed by refiners. Through American Power Group’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.

American Power Group’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique, non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run at the same time on diesel and different types of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time. It is an innovative non-invasive energy enhancement system.

Concerning the Company’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture boosts the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a wide set of engine models and end-market applications demands no engine modifications.

American Power Group’s Turbocharged Natural Gas® Dual Fuel System for stationary and vehicular engines has met specific anti-tampering design, componentry, and emission compliance criteria and guidelines as set by the EPA (Environmental Protection Agency). This includes the new EPA Clean Alternative Fuel Vehicle Conversion regulations. Dual Fuel is also known as “Mixed Fuel”. It is defined as the simultaneous combustion of two fuels.

American Power Group Corp. (APGI), closed Friday's trading session at $0.0915, up 1.67%, on 30,937 volume with 5 trades. The average volume for the last 3 months is 48,269 and the stock's 52-week low/high is $0.0025/$0.1195.


The QualityStocks Company Corner

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

Vertically integrated Canadian cannabis company The Flowr Corporation (TSX.V: FLWR) obtained its sales license from Health Canada in August of this year, thereby permitting FLWR to sell to both the medical and the adult-use recreational markets. To view the full article, visit:

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.68, up 1.66%, on 17,800 volume with 55 trades. The average volume for the last 3 months is 131,500 and the stock's 52-week low/high is $3.11/$8.00.

Recent News


QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals Corp.’s (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) efforts to “reawaken the promise” of Canada’s historically rich lithium fields in Manitoba are part of a broader strategy to build supplies of an in-demand metal from a close-to-home, North American source, and recent discoveries at the property are energizing the company’s prospects.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.226, up 2.73%, on 59,127 volume with 22 trades. The average volume for the last 3 months is 101,890 and the stock's 52-week low/high is $0.168/$1.46.

Recent News


Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Hydroponics Increasingly Key as Booming Cannabis Sector Goes to Next Level,” featuring Sugarmade, Inc. (OTCQB: SGMD). To hear the CannabisNewsAudio version, visit: To read the full editorial, visit:

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include:;; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.


CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.102, up 2.20%, on 701,627 volume with 114 trades. The average volume for the last 3 months is 2,600,241 and the stock's 52-week low/high is $0.05/$0.43.

Recent News


Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands, Inc. (OTC: ZNGY) is an energy and technology company operating in the emerging, next-generation, smart energy utility and conservation industries. Headquartered in Texas, Zenergy Brands is focused on providing a wide range of cost-saving energy solutions to both residential and enterprise customers. The products and services enable clients to not only achieve sustainability goals but also reduce their carbon footprints and, ultimately, add value to their bottom lines.

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.00035, up 16.67%, on 42,611,112 volume with 45 trades. The average volume for the last 3 months is 19,567,526 and the stock's 52-week low/high is $0.000192/$0.029.

Recent News


Generation Alpha, Inc. (GNAL)

The QualityStocks Daily Newsletter would like to spotlight Generation Alpha, Inc. (GNAL).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Political Wins Hold Promise for Strong Cannabis Strategies,” featuring Generation Alpha, Inc. (OTCQB: GNAL). To hear the CannabisNewsAudio version, visit: To read the full editorial, visit: Also today, the company was highlighted in an article examining how Michigan voters approved recreational marijuana in the recent mid-term elections and the state is now one of those with the lowest tax rates for cannabis. Didn’t Michigan need the revenue marijuana can bring? Was it playing for higher stakes? Several arguments can explain why Michigan chose the path it took.

Generation Alpha, Inc. (GNAL) was established in 2010 as a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to both commercial and individual growers in the United States. Originally named Solis Tek Inc., the company changed its name to Generation Alpha in September 2018 and announced an increased focus on providing innovative and must-have cannabis products and services to a growing industry.

“Generation Alpha for us means ‘new beginning’” said Generation Alpha CEO Alan Lien, when the name change was announced. “It is the new wave of how people and brands connect. We are excited with the transformation of our business strategy, our progress at our Arizona facility and the additional growth opportunities our team has identified elsewhere in the cannabis industry. While we are pleased with our innovation and progress in our Solis Tek lighting and Zelda Horticulture divisions, we believe?Generation Alpha?represents our philosophy of bringing the best cannabis products and services to the market. We are confident that this shift in our business strategy will create long-term shareholder value through diversified segments in the legalized cannabis industry.”

The name change reflects the company’s strategy to leverage business opportunities in different legalized cannabis spaces, including cultivation, processing and retail facilities. As part of that focus, Generation Alpha acts as the holding entity for a collection of companies that bring products and solutions to legal retail and commercial cannabis growers while utilizing its expertise to offer safe, quality and consistent products through its cultivation, processing, and retail facilities as well as branded products in both the medical and recreational markets. Along with its strong focus on the burgeoning cannabis market, Generational Alpha remains committed to developing and providing innovative products and services in both Solis Tek Digital Lighting, its lighting division, and Zelda Horticulture, its agricultural products division.

As part of a key piece of its cannabis focus, Generation Alpha acquired a cannabis cultivation and processing facility in Phoenix, Arizona, which is scheduled to begin operation in 2019. Currently in the design and development stage, the 70,000-square-foot facility will be one of the most technologically advanced cultivation and processing facilities in Arizona, which is a hot bed of cannabis cultivation in North America. Generation Alpha management is confident about the growth and profitability this facility provides as an essential component of its forward-thinking cannabis strategy.

Additional components of this strategy include the company’s GrowPro Solutions, Inc., a nationwide cannabis cultivator and processor and a variety of Generation Alpha brands, which include the innovation, design and selling of cannabis?products such as flower, oils and accessories in the legal medical and recreational markets.

The company’s Zelda Horticulture division offers commercial-grade rolling tables, greenhouses, PH stabilizer and nutrient products, and other agricultural products for cultivators around the world. Zelda’s custom-design cultivation options means its clients can count on increased agricultural productivity and efficiency.

Generation Alpha’s Solis Tek Digital Lighting division offers an extensive line of lighting equipment and accessories, including digital ballasts, reflectors,?complete lighting systems, single- and double-ended digital lamps, controllers and other accessories.?Each product is designed to help retail and commercial growers maximize quality and achieve higher yields and maximize quality.?

Redfund Capital Corp. (GNAL), closed the day's trading session at $0.52, even for the day, on 186,811 volume with 67 trades. The average volume for the last 3 months is 60,425 and the stock's 52-week low/high is $0.40/$2.64.

Recent News


Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF), with today’s announcement that the medical cannabis bill will go to the Knesset agenda, has commented on the potential of Israel to allow the medical export of its products to global markets. To view the full press release, visit:

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.3836, even or the day. The average volume for the last 3 months is 1,014 and the stock's 52-week low/high is $0.244/$0.505.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX) has grown to be a leading financial information website targeting Chinese investors in the U.S. and elsewhere. Founded in 1999, the company focuses on providing real-time market analysis, commentary and education-related services. In addition, CIIX offers consultative services aimed at small private companies, advertising services and public relations support products. Also today, the company was featured on MoneyTV with Donald Baillargeon (

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.59, off by 1.68%, on 188,749 volume with 101 trades. The average volume for the last 3 months is 582,906 and the stock's 52-week low/high is $0.365/$1.58.

Recent News


Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSX.V: RIV) was featured today in a report by examining how Canada has recently legalized cannabis at a recreational level, but cannabis in its whole form is not the only niche of the expansive industry that is currently benefiting from legalization. This boost has put the demand into hyperdrive for CBD-oil as CBD-products continue to diversify and experience a massive uptick in popularity in consumer markets.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.00, off by 1.48%, on 320,258 volume with 352 trades. The average volume for the last 3 months is 471,246 and the stock's 52-week low/high is $3.18/$11.82.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) today announced that it ranked on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing companies in North America. Net Element grew 183% percent during this period.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.28, off by 3.38%, on 43,283 volume with 283 trades. The average volume for the last 3 months is 285,864 and the stock's 52-week low/high is $3.665/$33.51.

Recent News


Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

As the market for cannabis products and recreational marijuana begins to catch fire following Canada’s nationwide full-use legalization of the plant, Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1), operating through wholly owned subsidiary 7ACRES, has positioned itself to provide premium High-End Cannabis coast-to-coast while beginning to access international markets as well.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.30, off by 2.26%, on 237,940 volume with 239 trades. The average volume for the last 3 months is 935,786 and the stock's 52-week low/high is $0.95/$2.79.

Recent News



The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (NUGL) was featured today on MoneyTV with Donald Baillargeon (, where founder CJ Melone and VP of Sales Bob Waters spoke of their cannabis search app.

NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.96, off by 2.00%, on 64,942 volume with 76 trades. The average volume for the last 3 months is 190,806 and the stock's 52-week low/high is $0.405/$2.64.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Canaccord Genuity has turned bullish on The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), and its reasons are set out in an initiation report. The Canadian producer of organic cannabis is set for international expansion, say analysts from the investment bank’s research division. They have initiated coverage with a “Speculative Buy” rating and a price target of C$7.00 ($5.40), which is almost double the present value of the company’s shares (

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.5719, off by 4.89%, on 732,931 volume with 1,321 trades. The average volume for the last 3 months is 1,497,284 and the stock's 52-week low/high is $1.87/$7.894.

Recent News


CytoDyn Inc. (CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

CytoDyn Inc. (OTC.QB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, announces that data from its ongoing CD03 investigative trial with PRO 140 (leronlimab) as a single-agent subcutaneous (SC) therapy in HIV-1 infected patients has been accepted for a poster presentation at the 2019 Conference on Retroviruses and Opportunistic Infections (CROI).

CytoDyn Inc. (CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.551, off by 3.27%, on 189,789 volume with 35 trades. The average volume for the last 3 months is 236,276 and the stock's 52-week low/high is $0.40/$0.836.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” In this week’s episode, SinglePoint CEO Greg Lambrecht reiterated the company’s recent announcement that it has secured $5 million in financing from an existing institutional shareholder. To view the full interview, visit: To view the full press release, visit:

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0219, off by 4.37%, on 6,135,915 volume with 240 trades. The average volume for the last 3 months is 4,499,937 and the stock's 52-week low/high is $0.0219/$0.133.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.